Related Experiment Videos
Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy
European Heart Journal
|June 14, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Animal health and welfare as a public good: what do the public think?
Agriculture and human values·2024
Loss-of-function desmoplakin I and II mutations underlie dominant arrhythmogenic cardiomyopathy with a hair and skin phenotype.
The British journal of dermatology·2018
The Global Engagement in Care Convening: Recommended Actions to Improve Health Outcomes for People Living With HIV.
AIDS education and prevention : official publication of the International Society for AIDS Education·2016
Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.
European journal of medical genetics·2015
RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.
European heart journal·2026
Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.
European heart journal·2026
Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis.
European heart journal·2026
Risk factors and coronary events: attenuation of the association in secondary prevention.
European heart journal·2026
Pre-Transplant Left Atrial Volume Index and One-Year Morbidity After Kidney Transplantation.
Clinical transplantation·2026
Management of Recurrent C3 Glomerulopathy After Kidney Transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Sex Based Differences in Association Between Plaque Burden and Ischemia -- a CREDENCE Trial Substudy.
European heart journal. Cardiovascular Imaging·2026